Postpartum hemorrhage (PPH) is among the most significant causes of maternal death worldwide. The time of diagnosing and the proper management of hemorrhage are essential in preventing maternal mortality. The current study aimed to evaluate the effect of Bakri balloon on the management of PPH. Bakri balloon was effective in controlling PPH of 92.3% of patients. The most frequent indications for using Bakri balloon was uterine atony (46.1%). Furthermore, Bakri balloon is among the simplest and low invasive methods that can be used to control PPH before invasion methods, like hysterectomy.
Introduction
ostpartum hemorrhage (PPH) is the most common cause of maternal mortality worldwide. There are two types of PPH; 1. Primary PPH that appears as bleeding during the first 24 hours after delivery; and 2. Secondary PPH, developed 24 hours and up to 6 weeks after postpartum [1] . PPH control depends on its cause. PPH can be associated with severe and widespread complications, including hypovolemic shock, renal dysfunction and coagulation problems [2] . The first-line treatment method for this condition is conservative management and the use of uterotonics, including oxytocin and prostaglandin. The second-line option includes the use of uterine packing, intrauterine balloon tamponade, external compression with uterine sutures, and uterine artery embolization [2] . If none of these options was effective, hysterectomy is required. Hysterectomy may be associated with more blood loss and many short-and long-term complications, such as injury to other organs, infection and impaired wound healing, fertility loss, prolonged healing period, and so on [3] .
Balloon tamponade has been suggested as an alternative method, which can significantly control PPH [4] . The efficacy of Bakri balloon tamponade has also been reported in various studies as a new tool to control PPH with a high success rate [5] . The balloon is easily inserted and quickly removed and its special shape and silicone material prevents the balloon from adhering to the inner layer of the uterus, causes sufficient pressure to tampon the uterus, and extensively controls bleeding. In addition, the exact rate of simultaneous blood loss is assessed by its drainage port [6] . Although the balloon may seem useful in controlling PPH, studies are limited regarding the Bakri balloon and its effect on reducing PPH, particularly in Iran. Therefore, this study aimed to evaluate the effect of Bakri balloon on controlling PPH among hospitalized patients.
Materials and Methods
This case series study was conducted from October 2015 to March 2017 in Kosar Hospital in Qazvin City, Iran. The study participants were patients whose PPH failed to respond to pharmacological treatment (e.g. oxytocin, methylergonovine, and misoprostol); thus, Bakri balloon was used to control their PPH.
Information on age, occupation, residence place, the number of births, gestational age, hospitalization cause, delivery method, serum hemoglobin level before and after delivery, the duration of stay, intensive care unit (ICU) admission, blood transfusion, indication and the duration of using Bakri balloon, and Bakri balloon effect on bleeding control were collected from the patients' records.
Results
The collected results reported that the most common cause of hospitalization was vaginal bleeding (46.2%). Eleven (84.7%) patients had Caesarean-section (C-section); 7 of which were due to previous C-section, one due to twin pregnancy, and 3 because of a drop in the fetal heart rate. Twelve (92.3%) patients were admitted to ICU for at least 12 hours, and 11 (84.7%) patients required blood transfusions and blood products. The Mean±SD serum hemoglobin concentration in patients before and after delivery were 12.4±1.8 and 9.2±1.1g/dL, respectively. The most frequent cause of Bakri balloon use was uterine atony (46.1%), followed by Placenta Accreta (30.8%), and Placenta Percreta (23.1%). The Mean±SD duration of stay for Bakri balloon in the uterus was 27±18 h. The use of Bakri balloon was effective in controlling PPH in 12 (92.3%) patients, including all those with vaginal deliveries and 90.9% of those with C-section. In one case, where PPH failed to respond to medical procedures and the use of Bakri balloon due to Placenta Percreta, hysterectomy was performed.
Conclusion
The present study revealed the Bakri balloon use was more effective in controlling PPH in 12 (92.3%) patients, including all women with vaginal delivery and 90.9% of women with C-section, compared to conventional medication use. In thea study by Vitthala et al. on 15 patients, the overall success rate of the Bakri balloon use in controlling PPH was reported as 80% [7] . In their study, like the present study, PPH was 100% controlled in women with vaginal delivery; whereas, Bakri balloon use was effective in only 57% of women with C-section. Georgiou and Wang et al. reported the overall success rate of the Bakri balloon in PPH control as 91.5% and 91.6%, respectively [8, 9] . This information is close to the results of our study. According to Aibar et al., the overall rate of success of Bakri balloon use in PPH control was equal to 87.5%, and for patients with vaginal delivery, it was 100% [10] . The most common reason for the use of Bakri balloon in their study was uterine atony (33.3%).
Consistent with their study, our results suggested that Bakri balloon use was quite effective in controlling PPH in patients with vaginal delivery. Furthermore, uterine atony with 46.1% was the most common reason for the use of Bakri balloon. Overall, it seems that the Bakri balloon is one of the simple, feasibly-used, and low-invasive procedures with no serious complications; thus, it can be used in PPH control before invasive procedures, like s hysterectomy. It also reduces the bleeding, the need for blood transfusions, and hospital stay duration.
One of the limitations of the present study was the small sample size and the limited number of variables included in the patients' record. Therefore, to be able to widely use the Bakri balloon in controlling PPH, it is necessary to conduct research studies with a larger statistical population and investigate more variables comparable with other methods in PPH control.
Ethical Considerations

Compliance with ethical guidelines
This study was approved by the Ethics Committee of Qazvin University of Medical Sciences (Code: IR.QUMS. REC.1397.051).
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. 
‫موردی‬
‫موارد‬ ‫گزارش‬ ‫زایمان:‬ ‫از‬ ‫بعد‬ ‫خونریزی‬ ‫کنترل‬ ‫در‬ ‫بکری‬ ‫بالون‬ ‫تأثیر‬
